{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:59:09Z","timestamp":1768867149563,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Birgit Heider-Lips for the purification of Adx and AdR"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jsbmb.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T16:07:48Z","timestamp":1462032468000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation"],"prefix":"10.1016","volume":"163","author":[{"given":"Lina","family":"Schiffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Rose","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Brixius-Anderko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Zapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2016.04.004_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.ackd.2015.03.002","article-title":"Mineralocorticoid and apparent mineralocorticoid syndromes of secondary hypertension","volume":"22","author":"Ardhanari","year":"2015","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0010","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.med.48.1.231","article-title":"Glucocorticoid and Mineralocorticoid receptors: biology and clinical relevance","volume":"48","author":"Funder","year":"1997","journal-title":"Ann. Rev. Med."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0015","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00004872-200208000-00002","article-title":"Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system","volume":"20","author":"Young","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0020","series-title":"The Ubiquitous Roles of Cytochrome P450 Proteins","first-page":"361","article-title":"Cytochrome P450 and steroid hormone biosynthesis","author":"Bernhardt","year":"2016"},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mce.2003.10.021","article-title":"Mineralocorticoid receptor binding, structure and function","volume":"217","author":"Rogerson","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0030","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1515\/BC.2002.174","article-title":"The human steroid hydroxylases CYP11B1 and CYP11B2","volume":"383","author":"Bureik","year":"2002","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0035","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.11.008","article-title":"Modulation of aldosterone and cortisol synthesis on the molecular level","volume":"215","author":"Lisurek","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsbmb.2014.10.011","article-title":"The CYP11B subfamily","volume":"151","author":"Schiffer","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsbmb.2012.03.002","article-title":"Human aldosterone synthase: recombinant expression in E. coli and purification enables a detailed biochemical analysis of the protein on the molecular level","volume":"132","author":"Hobler","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0006-291X(05)81058-7","article-title":"Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism","volume":"173","author":"Kawamoto","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-4658.2008.06253.x","article-title":"Purification and functional characterization of human 11\u03b2 hydroxylase expressed in Escherichia coli","volume":"275","author":"Z\u00f6llner","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0060","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/mend-5-10-1513","article-title":"The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex","volume":"5","author":"Curnow","year":"1991","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0065","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbagen.2006.07.017","article-title":"Cytochrome P450 systems\u2014biological variations of electron transport chains","volume":"1770","author":"Hannemann","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.mce.2008.09.014","article-title":"Altered corticosteroid biosynthesis in essential hypertension: a digenic phenomenon","volume":"300","author":"Davies","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0075","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0140-6736(62)92199-2","article-title":"The effetcs of spironolactone and chlorthalidoneon arterial pressure","volume":"279","author":"Cranston","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0080","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1001\/jama.1966.03110240051022","article-title":"Treatment of hypertension with spironolactone: double-blind study","volume":"198","author":"Wolf","year":"1966","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. E. J. Med."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0095","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0b013e3283599b6a","article-title":"Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension","volume":"31","author":"Colussi","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0105","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jps.2600530427","article-title":"Oral absorption with various preparations of spironolactone in dogs","volume":"53","author":"Kagawa","year":"1964","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0110","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0022-3565(25)29552-0","article-title":"Pharmacokinetics of spironolatone, canrenone and canrenoate-K in humans","volume":"185","author":"Sad\u00e9e","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0115","doi-asserted-by":"crossref","DOI":"10.1002\/jps.2600660841","article-title":"Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk","volume":"66","author":"Phelps","year":"1977","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-46-2-338","article-title":"Interaction of digitalis and spironolactone with human sex steroid receptors","volume":"46","author":"Rifka","year":"1978","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","article-title":"The evolution of aldosterone antagonists","volume":"217","author":"Garthwaite","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0130","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00499670","article-title":"Stimulation of aldosterone production in vitro and its inhibition by spironolactone","volume":"273","author":"Erbler","year":"1972","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00501155","article-title":"On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitro","volume":"277","author":"Erbler","year":"1973","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0145","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/endo-99-4-1097","article-title":"Effects of spironolactone, canrenone and canrenoate-K on cytochrome P450, and 11\u03b2- and 18-hydroxylation in bovine and human adrenal cortical mitochondria1","volume":"99","author":"Cheng","year":"1976","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12934-015-0209-5","article-title":"A recombinant CYP11B1 dependent Escherichia coli biocatalyst for selective cortisol production and optimization towards a preparative scale","volume":"14","author":"Schiffer","year":"2015","journal-title":"Microbial. Cell Fact."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0155","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0160","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx500444e","article-title":"Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals","volume":"28","author":"Rendic","year":"2015","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.toxlet.2012.07.020","article-title":"Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination\u2014insights from metandienone metabolism","volume":"213","author":"Parr","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0170","doi-asserted-by":"crossref","first-page":"20895","DOI":"10.1074\/jbc.270.36.20895","article-title":"Novel involvement of a mitochondrial steroid hydroxylase (P450c11) in xenobiotic metabolism","volume":"270","author":"Lund","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/dmd.115.066829","article-title":"metabolism of oral turinabol by human steroid hormone\u2013synthesizing cytochrome P450 enzymes","volume":"44","author":"Schiffer","year":"2016","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0180","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/S0021-9258(20)82245-5","article-title":"The carbon monoxide-binding pigment of liver microsomes: II. Solubilization, purification and properties","volume":"239","author":"Omura","year":"1964","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-5793(75)80658-2","article-title":"Purification and crystallization of NADPH-adrenodoxin reductase from bovine adrenocortical mitochondria","volume":"52","author":"Sugiyama","year":"1975","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0190","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1248\/bpb.16.627","article-title":"Direct expression of adrenodoxin reductase in Escherichia coli and the functional characterization","volume":"16","author":"Sagara","year":"1993","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0195","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(92)91349-U","article-title":"Expression of bovine adrenodoxin in E. coli and site-directed mutagenesis of\/2 FE-2S\/cluster ligands","volume":"188","author":"Uhlmann","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0200","doi-asserted-by":"crossref","first-page":"34269","DOI":"10.1074\/jbc.M402798200","article-title":"Stripping down the mitochondrial cholesterol hydroxylase system, a kinetics study","volume":"279","author":"Schiffler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0205","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1021\/bi00812a009","article-title":"Studies on the nature of the type I and type II spectral changes in liver microsomes","volume":"9","author":"Schenkman","year":"1970","journal-title":"Biochemistry"},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01283159","article-title":"Steroidogenic electron transport in adrenal cortex mitochondria","volume":"45","author":"Lambeth","year":"1982","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0215","doi-asserted-by":"crossref","first-page":"12088","DOI":"10.1016\/S0021-9258(19)86433-5","article-title":"Participation of the membrane in the side chain cleavage of cholesterol. Reconstitution of cytochrome P-450scc into phospholipid vesicles","volume":"254","author":"Seybert","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0220","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1016\/S0021-9258(17)34297-7","article-title":"The participation of a second molecule of adrenodoxin in cytochrome P-450-catalyzed 11beta hydroxylation","volume":"253","author":"Seybert","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/me.2012-1287","article-title":"Structural insights into aldosterone synthase substrate specificity and targeted inhibition","volume":"27","author":"Strushkevich","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cclet.2012.01.003","article-title":"Structural characterization of 1\u03b2,11\u03b1-dihydroxycanrenone biotrans-formed from canrenone by Aspergillus ochraceus SIT34205","volume":"23","author":"Rong","year":"2012","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0235","first-page":"12","article-title":"Biocatalysis and biotransformation processes\u2014an insight","volume":"1","author":"Kaushik","year":"2014","journal-title":"Scitech J."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0240","doi-asserted-by":"crossref","first-page":"31283","DOI":"10.1074\/jbc.M504098200","article-title":"A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor","volume":"280","author":"Bledsoe","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0245","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jsbmb.2016.04.004_bib0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/JOE-11-0372","article-title":"Mechanisms of ligand specificity of the mineralocorticoid receptor","volume":"213","author":"Fuller","year":"2012","journal-title":"J. Endocrinol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016301005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076016301005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:52:30Z","timestamp":1760745150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076016301005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":50,"alternative-id":["S0960076016301005"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.04.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}